Imatinib for the treatment of patients with unresectable and/or metastatic gastrointestinal stromal tumours; systematic review and economic evaluation

Wilson, J., Connock, M., Song, F., Yao, G. L., Fry-Smith, A., Raftery, J. and Peake, D. (2005) Imatinib for the treatment of patients with unresectable and/or metastatic gastrointestinal stromal tumours; systematic review and economic evaluation. Health Technology Assessment, 9 (25). pp. 1-142. ISSN 2046-4924

Full text not available from this repository. (Request a copy)

Item Type:	Article
Faculty \ School:	Faculty of Medicine and Health Sciences > Norwich Medical School
UEA Research Groups:	Faculty of Medicine and Health Sciences > Research Groups > Public Health and Health Services Research (former - to 2023) Faculty of Medicine and Health Sciences > Research Groups > Health Services and Primary Care Faculty of Medicine and Health Sciences > Research Groups > Epidemiology and Public Health Faculty of Medicine and Health Sciences > Research Centres > Population Health
Depositing User:	EPrints Services
Date Deposited:	25 Nov 2010 11:12
Last Modified:	03 Apr 2024 12:30
URI:	https://ueaeprints.uea.ac.uk/id/eprint/14912
DOI:	10.3310/hta9250

Actions (login required)

View Item